tirzepatide and breastfeeding Is Safe While Breastfeeding? FDA Guidance & Alternatives Tirzepatide and Breastfeeding: What Moms

Efficacy: What the Head-to-Head Trial Showed In the head-to-head 72-week SURMOUNT-5 trial of 751 adults with obesity without diabetes, tirzepatide reduced body weight by an average of about 20.2% versus 13.7% for semaglutide

If youre eating fewer calories because of GLP-1 treatment, theres a good chance youre eating less iron, too

Heres how our partnership with Revolution PT supports you: Full Metabolic Profiling & Custom Activity Plans Revolution PT exercise physiologists will design a personalized activity plan that keeps your heart rate in the optimal fat-burning range while supporting muscle retention

Adjust dosage gradually over time

Reserve your appointment for this treatment: Please remember that an initial consultation is REQUIRED with ALL first appointments